Neurocognitive Performance in Public Officials (NCT07650890) | Clinical Trial Compass
CompletedNot Applicable
Neurocognitive Performance in Public Officials
Turkey (Türkiye)82 participantsStarted 2025-11-03
Plain-language summary
Public employees are exposed to varying levels of cognitive, physical, and psychosocial demands depending on the nature of their duties. In particular, armed public employees work under conditions that require rapid responses to environmental stimuli, effective use of attentional processes, and accurate decision-making within a limited time. These occupational demands may influence reaction time, neurocognitive performance, quality of life, and activity-role balance. Therefore, the aim of this study was to compare the neurocognitive performance of armed and unarmed public employees.
A total of 82 public employees, including 41 armed and 41 unarmed participants, were included in the study. Reaction time performance was assessed using the Light Trainer system. Neurocognitive performance was evaluated using the Stroop Test and the Digit Span Test. Quality of life was assessed using the Short Form-36 Health Survey (SF-36), and activity-role balance was evaluated using the Activity Role Balance Questionnaire.
Who can participate
Age range
25 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged between 25 and 35 years.
* Actively employed as a public official for at least 3 years.
* A score of 26 or higher on the Mini-Mental State Examination (MMSE).
* Currently employed full-time.
* Able to understand and speak Turkish.
* Willing to participate in the study and provide informed consent.
Exclusion Criteria:
* Presence of a diagnosed neurological or psychiatric disorder.
* History of traumatic brain injury or severe head trauma within the past 6 months.
* Presence of an orthopedic condition or injury that may affect upper or lower extremity function.
* Presence of visual, auditory, or other sensory impairments that may interfere with test performance.
* Current use of medications or history of substance use that may affect cognitive performance.
* Previous exposure to or administration of the neurocognitive tests used in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.